Financial Performance - The company's operating revenue for 2020 was CNY 1,861,749,308.55, representing an increase of 18.65% compared to CNY 1,569,075,036.16 in 2019[16] - The net profit attributable to shareholders for 2020 was CNY 196,187,719.89, a growth of 31.00% from CNY 149,762,694.22 in the previous year[16] - The net cash flow from operating activities reached CNY 320,013,995.90, up by 25.51% from CNY 254,973,691.39 in 2019[16] - Basic earnings per share increased to CNY 1.42, a rise of 25.66% compared to CNY 1.13 in 2019[16] - Total assets at the end of 2020 amounted to CNY 2,540,212,366.99, reflecting a 13.38% increase from CNY 2,240,386,397.11 at the end of 2019[16] - The company's net assets attributable to shareholders grew to CNY 1,457,503,003.93, marking a 13.67% increase from CNY 1,282,236,643.49 in 2019[16] - The company reported a diluted earnings per share of CNY 1.48, which is a 30.97% increase from CNY 1.13 in 2019[16] - The company’s weighted average return on equity was 14.37%, up from 12.18% in the previous year[16] - The total revenue for 2020 was 30,455.41 million, a significant rise from 4,310.38 million in 2019[23] Dividend Policy - The company plans to distribute a cash dividend of CNY 4 per 10 shares, based on a total of 138,010,500 shares[4] - The total distributable profit for the year was RMB 783,126,692.64, with cash dividends amounting to RMB 55,204,200, representing 100% of the profit distribution[120][121] - The proposed profit distribution plan includes a cash dividend of RMB 4.00 per 10 shares, totaling RMB 55,204,200, and a capital reserve increase of 5 shares for every 10 shares held, resulting in a total share capital of 207,015,750 shares[121][122] - The cash dividend payout ratio for 2020 was 28.14% of the net profit attributable to shareholders[124] - The company has consistently increased its cash dividends over the past three years, with the 2020 cash dividend being higher than the 2019 dividend of RMB 3.00 per 10 shares[124] Market Position and Strategy - The pesticide export volume in China reached 239.5 million tons in 2020, representing a year-on-year growth of 29.3%[28] - The export value of pesticides from China was 11.68 billion, reflecting a year-on-year increase of 14.6%[28] - The global crop protection market is projected to reach 66.70 billion by 2023, with a compound annual growth rate of 3% from 2018 to 2023[26] - The company holds a leading position in several niche markets, including chlorfenapyr and thiamethoxam, and has received multiple industry awards[29] - The company is focused on the research and development of new, efficient, and low-toxicity pesticides, aligning with industry trends towards sustainable agricultural practices[29] - The company achieved operating revenue of 1,861.75 million RMB, an increase of 18.65% compared to the previous year[44] - The pesticide industry accounted for 99.31% of total revenue, with revenue from pesticide raw materials at ¥1,150,440,808.31, up 13.48% year-on-year[58] - Overseas sales increased by 55.78% to ¥1,085,356,291.44, while domestic sales decreased by 11.00% to ¥776,393,017.11[58] Research and Development - The company holds 53 patents and has established itself as a national high-tech enterprise with a strong R&D team primarily composed of PhDs and Masters[37] - The company has developed over 600 pesticide active ingredients, indicating a diverse product portfolio[38] - The company has obtained over 100 pesticide registration certificates and more than 50 production licenses in the domestic market, showcasing its rich license resources[39] - The company’s R&D expenses in 2020 amounted to ¥59.30 million, a 34.20% increase compared to ¥44.19 million in 2019, reflecting increased investment in new project development[69] - The proportion of R&D personnel increased to 16.07% of total employees, up from 11.97% in 2019, indicating a focus on enhancing R&D capabilities[70] Operational Efficiency - The company has implemented multiple technical transformation projects aimed at increasing capacity, saving energy, and reducing emissions[44] - The company has a designed capacity of 7,950 tons/year for active ingredients and intermediates, with a capacity utilization rate of 66.40%[47] - The company is currently constructing an additional capacity of 15,500 tons/year for active ingredients and intermediates[47] - The company maintains a production capacity for formulations at 2,800 tons/year, with a capacity utilization rate of 38.16%[47] - The company aims to enhance daily operational efficiency, reduce operating costs, and improve overall business performance[151] Risk Management - The company faced risks including raw material supply and price fluctuations, exchange rate risks, and environmental protection risks[4] - Raw material costs significantly impact operating costs and gross margins, with fluctuations posing risks to profitability[108] - The company employs measures to manage foreign exchange risks due to a high proportion of overseas sales revenue[108] Corporate Governance - The company has established a corporate culture centered around its vision, mission, and values, enhancing employee cohesion and management thinking[45] - The company is committed to improving its EHS management system to prevent major safety and environmental incidents[106] - The company has a long-term commitment to dividend distribution, which has been in normal execution since December 2016[132] - The company has outlined specific actions to take if future business expansions lead to potential competition with its existing operations[137] Social Responsibility - The company made a donation of over 100,000 yuan to the Nanjing Charity Federation and provided 5,000 N95 masks to the Wuhan Red Cross during the pandemic[195] - The company donated 2,525,000 yuan to the Nanjing University Education Development Foundation to support educational initiatives[195] - In 2020, the company invested 1,062 million in safety production measures, with no major safety incidents reported during the year[197] Shareholder Relations - The company has implemented measures to protect the interests of its shareholders, including a commitment from key executives to not resign during compliance periods[135] - The company will conduct share reductions through legal and compliant methods, including but not limited to centralized bidding transactions and block trades[130] - The company’s major shareholder will not transfer more than 25% of their total shareholding during their tenure as a director or senior management[129]

江苏中旗科技股份有限公司 2020 年第三季度报告全文 1 江苏中旗科技股份有限公司 2020 年第三季度报告全文 第一节 重要提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真 实、准确、完整，不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和 连带的法律责任。 所有董事均已出席了审议本次季报的董事会会议。 公司负责人吴耀军、主管会计工作负责人顾游及会计机构负责人(会计主管 人员)刘红妮声明：保证季度报告中财务报表的真实、准确、完整。 江苏中旗科技股份有限公司 2020 年第三季度报告 2020-068 2020 年 10 月 √ 适用 □ 不适用 单位：元 2 江苏中旗科技股份有限公司 2020 年第三季度报告全文 第二节 公司基本情况 一、主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □ 是 √ 否 | | 本报告期末 | 上年度末 | | 本报告期末比上年度末增减 | | --- | --- | --- | --- | --- | | 总资产（元） | 2,427,560,048.47 | 2,240,386,397.11 | | 8.35% | | 归属于上 ...

Financial Performance - The company's operating revenue for the first half of 2020 was CNY 1,006,626,047.46, representing a 13.33% increase compared to CNY 888,222,150.69 in the same period last year[18]. - The net profit attributable to shareholders of the listed company was CNY 123,817,291.22, up 26.12% from CNY 98,177,517.19 year-on-year[18]. - The net profit after deducting non-recurring gains and losses was CNY 114,724,902.07, an increase of 18.05% compared to CNY 97,179,730.45 in the previous year[18]. - The basic earnings per share rose to CNY 0.94, reflecting a 27.03% increase from CNY 0.74 in the same period last year[18]. - The company achieved operating revenue of CNY 1,006,626,047.46, an increase of 13.33% compared to the same period last year[39]. - The net profit attributable to shareholders reached CNY 12,381,730, an increase of 26.12% year-on-year[39]. - Research and development investment increased by 45.54% to CNY 31,879,659.32, reflecting a focus on new product development[43]. - The gross margin for pesticide products was 25.12%, up by 2.03% compared to the previous year[45]. - The company reported a significant decrease in financial expenses by 64.16% to CNY 3,532,641.20, mainly due to exchange gains and government subsidies[42]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 2,468,580,275.07, a 10.19% increase from CNY 2,240,386,397.11 at the end of the previous year[18]. - The net assets attributable to shareholders of the listed company increased to CNY 1,370,011,752.55, up 6.85% from CNY 1,282,236,643.49 at the end of the previous year[18]. - The total liabilities of the company were CNY 1,085,825,912.23, compared to CNY 950,216,942.31 at the end of 2019, which is an increase of approximately 14.3%[156]. - The company's equity attributable to shareholders increased to CNY 1,370,011,752.55 from CNY 1,282,236,643.49, representing a growth of about 6.8%[157]. - The total current liabilities increased to CNY 400,425,648.12, compared to CNY 286,968,952.85, reflecting an increase of 39.4%[161]. Cash Flow - The company reported a net cash flow from operating activities of CNY 104,202,438.14, a decrease of 12.58% compared to CNY 119,203,832.29 in the same period last year[18]. - Cash and cash equivalents increased by 215.89% to CNY 104,465,962.22, driven by changes in financing activities[43]. - The cash flow from operating activities generated a net amount of CNY 104,202,438.14, down from CNY 119,203,832.29 in the previous year[171]. - The total cash inflow from investment activities was ¥419,939,589.65, significantly higher than ¥3,087,248.16 in the previous year[175]. - The cash and cash equivalents at the end of the period amounted to CNY 504,421,573.46, an increase from CNY 358,527,911.50 at the end of the first half of 2019[172]. Research and Development - The company emphasizes research and development, having been recognized as a high-tech enterprise since 2010 and a key high-tech enterprise under the National Torch Program since 2014[33]. - The company has developed over 600 pesticide active ingredients, indicating a strong product variety and market presence[33]. - The company has a comprehensive R&D mechanism, allowing it to develop and industrialize new products effectively, supported by a strong team of researchers[33]. Risks and Challenges - The company faces risks including raw material supply and price fluctuations, exchange rate risks, and environmental protection and safety production risks[4]. - The company’s production costs are significantly influenced by raw material prices, which have shown volatility, impacting gross margins[29]. - The company is exposed to exchange rate fluctuations due to a high proportion of overseas sales, primarily settled in USD[80]. Environmental Compliance - The company has maintained compliance with pollutant discharge standards and has timely paid discharge fees[117]. - The total COD emissions were 51.03 tons, with a discharge concentration of 286 mg/l, below the standard of 1000 mg/l[112]. - The company has implemented measures to ensure compliance with pollution discharge standards, with no instances of exceeding discharge limits reported[112]. Shareholder and Equity Information - The total number of shares increased from 132,030,000 to 138,049,500, reflecting a change of 6,019,500 shares due to the issuance of restricted stock[124]. - The company granted 6,019,500 restricted shares to 263 incentive objects, with the listing date set for June 9, 2020[124]. - The company did not distribute cash dividends or issue bonus shares for the reporting period[85]. Subsidiaries and Corporate Structure - The company has a total of 5 subsidiaries included in the consolidated financial statements, with 100% ownership in Jiangsu Fulai Ge International Trade Co., Ltd. and Jiangsu Hongfeng Equity Investment Co., Ltd.[189][190]. - The company established a new subsidiary, Jiangsu Zhongqi Crop Protection Technology Co., Ltd., during the reporting period[190].

Financial Performance - Total revenue for Q1 2020 was ¥456,920,913.02, a decrease of 16.92% compared to ¥549,947,693.26 in the same period last year[7] - Net profit attributable to shareholders was ¥50,171,426.22, down 32.94% from ¥74,820,744.06 year-on-year[7] - Net profit excluding non-recurring gains and losses was ¥47,973,226.45, a decline of 35.40% compared to ¥74,264,397.24 in the previous year[7] - Basic earnings per share decreased by 33.33% to ¥0.38 from ¥0.57 year-on-year[7] - The company reported a revenue of 456.92 million CNY for Q1 2020, a decrease of 16.92% compared to the same period last year[17] - The net profit attributable to shareholders was 50.17 million CNY, down 32.94% year-on-year, primarily due to decreased sales and increased fixed production costs[16] - The company’s operating revenue for Q1 2020 was CNY 340,535,194.41, a decrease of 18.8% compared to CNY 419,131,159.19 in the same period last year[49] - The net profit for Q1 2020 was CNY 49,325,486.70, down 33.7% from CNY 74,316,888.54 in Q1 2019[47] - The total profit for Q1 2020 was CNY 59,493,510.17, a decrease of 34.1% from CNY 90,295,811.24 in the previous year[46] - The company's operating profit for Q1 2020 was CNY 60,142,658.44, down 33.8% from CNY 90,872,569.24 in Q1 2019[46] Cash Flow - The net cash flow from operating activities was -¥9,356,916.97, an improvement of 59.03% from -¥22,836,248.62 in the same period last year[7] - Cash inflow from operating activities totaled 277,293,348.03 yuan, down from 392,757,674.83 yuan in the previous period[57] - Cash outflow from operating activities was 273,450,653.33 yuan, compared to 412,756,632.69 yuan in the previous period, indicating a decrease in cash outflow[57] - The cash inflow from operating activities in Q1 2020 was CNY 331,988,372.82, compared to CNY 486,827,039.72 in the same period last year, indicating a decrease of 31.8%[53] - The net cash flow from operating activities was -9,356,916.97 yuan, compared to -22,836,248.62 yuan in the previous period, indicating an improvement[54] - Total cash inflow from financing activities was 52,464,140.91 yuan, down from 151,987,657.16 yuan in the previous period[55] - The net cash flow from investing activities was -10,660,894.22 yuan, compared to -41,077,695.19 yuan in the previous period, showing a significant reduction in cash outflow[54] - The company experienced a net decrease in cash and cash equivalents of -65,086,595.00 yuan, compared to -80,455,599.89 yuan in the previous period[55] Assets and Liabilities - Total assets at the end of the reporting period were ¥2,292,420,347.39, an increase of 2.32% from ¥2,240,386,397.11 at the end of the previous year[7] - Accounts receivable increased by 70.94% to 244.97 million CNY, attributed to increased sales activities compared to the previous quarter[16] - The company's total assets amounted to CNY 2,292,420,347.39, an increase from CNY 2,240,386,397.11 at the end of 2019[36] - The company's cash and cash equivalents decreased to CNY 447,656,934.62 from CNY 471,262,792.53, reflecting a decline of approximately 5.03%[36] - Total liabilities as of March 31, 2020, were CNY 947,204,856.66, slightly down from CNY 950,216,942.31[39] - The total current liabilities of the company were CNY 547,243,886.23, compared to CNY 542,346,751.90 at the end of 2019, indicating a slight increase[36] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 8,110[10] - The largest shareholder, Wu Yaojun, holds 30.10% of the shares, with 39,736,620 shares pledged[10] - Net assets attributable to shareholders increased by 4.23% to ¥1,336,475,894.56 from ¥1,282,236,643.49 at the end of the previous year[7] - Total equity attributable to shareholders increased to CNY 1,336,475,894.56 from CNY 1,282,236,643.49, reflecting a growth of approximately 4.2%[39] Operational Insights - The company plans to enhance procurement management to mitigate risks associated with raw material price fluctuations, which significantly impact operating costs[21] - The company is focused on optimizing investment management for new projects to minimize the impact of capital expenditures on profitability[22] - The company will continue to enhance safety and environmental management to mitigate risks associated with production processes in the pesticide industry[22] - The company has faced delays in project implementation due to environmental regulations and safety inspections, impacting production capacity[30] Research and Development - Research and development expenses for Q1 2020 were CNY 6,824,900.76, down from CNY 9,522,271.99 in the previous period, indicating a reduction of about 28.4%[45] - The company reported a decrease in research and development expenses to CNY 6,035,128.56 in Q1 2020 from CNY 9,037,609.36 in Q1 2019, a reduction of 33.2%[49] Fundraising and Investments - The total amount of raised funds is 36,548.01 million CNY, with 92.66 million CNY invested in the current quarter[28] - Cumulative changes in the use of raised funds amount to 25,550.77 million CNY, representing 69.91% of the total raised funds[28] - The company utilized CNY 10,003,562.61 of unutilized raised funds for permanent working capital, with the special account for raised funds being closed[30] - The company has invested CNY 6,568.86 million in projects prior to the arrival of raised funds, with no funds being replaced from the raised capital[30]

Financial Performance - The company's operating revenue for 2019 was ¥1,569,075,036.16, a decrease of 4.90% compared to ¥1,649,849,487.54 in 2018[16] - The net profit attributable to shareholders was ¥149,762,694.22, down 28.40% from ¥209,158,538.75 in the previous year[16] - The net profit after deducting non-recurring gains and losses was ¥145,452,313.42, a decline of 29.19% compared to ¥205,400,733.13 in 2018[16] - The basic earnings per share decreased to ¥1.13, down 28.48% from ¥1.58 in 2018[16] - The company's revenue for the pesticide industry reached ¥1,561,573,052.37, representing a year-on-year decrease of 4.94%[46] - The gross profit margin for the pesticide industry was 23.61%, a decline of 0.51% compared to the previous year[46] - Domestic sales amounted to ¥872,369,256.23, with a year-on-year increase of 4.73%, while overseas sales were ¥696,705,779.93, down 14.71%[46] - The total sales volume in the pesticide industry was 6,850.58 tons, showing a slight decrease of 0.32% from 2018[47] Assets and Liabilities - The total assets at the end of 2019 were ¥2,240,386,397.11, a slight increase of 0.09% from ¥2,238,334,869.43 at the end of 2018[16] - The net assets attributable to shareholders increased by 7.11% to ¥1,282,236,643.49 from ¥1,197,173,444.48 in 2018[16] - The company's fixed assets grew by 52.56% compared to the beginning of the period, primarily due to the completion of several construction projects[33] - The company's cash and cash equivalents decreased to ¥471,262,792.50, representing 21.03% of total assets, down by 3.23%[64] - The company's short-term borrowings decreased to ¥162,625,651.80, accounting for 7.26% of total assets, down by 2.67%[64] - The company's long-term borrowings increased to ¥269,857,756.50, representing 12.05% of total assets, up by 2.15%[64] Cash Flow - The cash flow from operating activities was ¥254,973,691.39, down 8.99% from ¥280,165,159.26 in the previous year[16] - The net cash flow from operating activities was ¥254,973,691.39, a decrease of 8.99% compared to the previous year[58] - The net cash flow from financing activities decreased by 197.91%, resulting in a net outflow of ¥95,213,022.41, attributed to loan repayments[58] Investment and R&D - The company has developed over 600 pesticide active ingredients, indicating a diverse product portfolio[35] - The company holds 46 patents and has a strong R&D team primarily composed of PhDs and Masters[34] - Research and development expenses for the year were ¥44,192,148.75, accounting for 2.82% of total revenue, down from 3.28% in 2018[55] - The company plans to invest in new pesticide projects at the Huai'an base and Nanjing new plant, and upgrade the Nanjing old plant facilities[83] - The company is investing 100 million RMB in R&D for new technologies aimed at enhancing product efficiency[105] Market Position and Strategy - The company holds a leading position in several niche markets, including chlorfluoropyrrolidine and thiamethoxam, and has received multiple industry awards in 2019[31] - The company aims to develop into a high-end fine chemical enterprise with international competitiveness, focusing on green technology and sustainable development[82] - The company plans to enhance its EHS management system to prevent major safety and environmental incidents throughout the year[83] - The company plans to reduce operational costs by 8% through efficiency improvements in the supply chain[101] Risk Management - The company faces risks including raw material supply and price fluctuations, exchange rate risks, and environmental protection risks[4] - The company’s cost structure is heavily influenced by raw material prices, which have shown volatility, affecting overall profitability[30] - The company will manage exchange rate risks through export trade financing and foreign exchange derivatives, as a significant portion of sales revenue comes from overseas[85] Profit Distribution - The company has a profit distribution policy prioritizing cash dividends, ensuring returns to investors while considering long-term development[89] - The company plans to distribute cash dividends of at least 20% of the distributable profits each year, or a cumulative total of 60% over three years[90] - In 2019, the company proposed a cash dividend of 3.00 RMB per 10 shares, totaling 39,609,000 RMB, which represents 26.45% of the distributable profits[95] - The total distributable profit for 2019 was 149,762,694.22 RMB, with the cash dividend amounting to 39,609,000 RMB[96] Environmental Compliance - The company is classified as a key pollutant discharge unit, with total COD emissions of 72.56 tons, below the regulatory limit of 582.246 tons[167] - The company has implemented a stable profit distribution policy to ensure reasonable returns for shareholders[163] - The company has established a wastewater treatment station that operates under a "one enterprise, one pipe" discharge policy, ensuring efficient management of wastewater[170] - The company has received administrative penalties but has completed the required rectifications without affecting normal operations[176] Shareholder Structure - The total share capital increased from 73,350,000 shares to 132,030,000 shares due to a capital reserve distribution plan approved on April 12, 2019, which involved a bonus issue of 8 shares for every 10 shares held[182] - The controlling shareholders hold a total of 26,475,900 shares, accounting for 48.1380% of the total share capital before the initial public offering[124] - Wu Yaojun, the largest shareholder, holds 30.10% of the shares, totaling 39,736,620 shares, with 9,934,155 shares pledged[190] - The second-largest shareholder, Zhou Xuejin, holds 12.88% of the shares, totaling 17,006,760 shares[190]

江苏中旗科技股份有限公司 2019 年第三季度报告全文 江苏中旗科技股份有限公司 2019 年第三季度报告 2019-061 2019 年 10 月 1 江苏中旗科技股份有限公司 2019 年第三季度报告全文 第一节 重要提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真 实、准确、完整，不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和 连带的法律责任。 所有董事均已出席了审议本次季报的董事会会议。 公司负责人吴耀军、主管会计工作负责人顾游及会计机构负责人(会计主管 人员)刘红妮声明：保证季度报告中财务报表的真实、准确、完整。 2 江苏中旗科技股份有限公司 2019 年第三季度报告全文 单位：人民币元 | 项目 | 年初至报告期期末金额 | 说明 | | --- | --- | --- | | 非流动资产处置损益（包括已计提资产减值准备的冲销部分） | -7,191.26 | | | 计入当期损益的政府补助（与企业业务密切相关，按照国家统 一标准定额或定量享受的政府补助除外） | 1,791,074.86 | | | 委托他人投资或管理资产的损益 | 2,806,975.27 | | ...

Financial Performance - Total revenue for the first half of 2019 was RMB 888,222,150.69, an increase of 11.54% compared to RMB 796,333,940.19 in the same period last year[18]. - Net profit attributable to shareholders was RMB 98,177,517.19, representing a growth of 20.61% from RMB 81,403,866.19 year-on-year[18]. - Net cash flow from operating activities surged to RMB 119,203,832.29, a remarkable increase of 778.11% compared to RMB 13,574,976.64 in the previous year[18]. - Basic and diluted earnings per share decreased to RMB 0.74, down 33.33% from RMB 1.11 in the same period last year[18]. - Total assets at the end of the reporting period were RMB 2,161,557,114.32, a decrease of 3.43% from RMB 2,238,334,869.43 at the end of the previous year[18]. - Net assets attributable to shareholders increased to RMB 1,238,056,785.60, up 3.41% from RMB 1,197,173,444.48 at the end of the previous year[18]. - The company achieved operating revenue of 888.22 million RMB, an increase of 11.54% compared to the same period last year[37]. - Net profit reached 98.18 million RMB, reflecting a growth of 20.61% year-on-year[37]. Research and Development - The company focuses on the research, production, and sales of new efficient and low-toxicity pesticides, primarily chemical pesticides used for controlling harmful agricultural pests[25]. - The company holds 46 patents and is recognized as a national high-tech enterprise, with a strong R&D team primarily composed of PhDs and Masters[30]. - The company has developed over 600 pesticide active ingredients, leveraging market research to select products with strong market potential[31]. - The company has invested a total of 50.34 million RMB in the R&D center project, which is now operational[38]. - Research and development expenses rose significantly to CNY 21,904,578.65 in the first half of 2019, up from CNY 10,931,052.97 in the first half of 2018, indicating a 100.5% increase[145]. Market and Competition - The company's revenue is significantly influenced by industry conditions, product development capabilities, and market competition, with a strong focus on capturing opportunities from the global pesticide industry's shift to developing countries[27]. - The company’s main business gross profit comes from its pesticide operations, which have shown strong market competitiveness and demand growth[28]. - The company’s ability to adapt to market changes and maintain a flexible production mechanism enhances its competitive edge in the pesticide market[31]. Financial Management and Investments - The company has established strategic supplier relationships with major multinational companies, ensuring stable supply and deepening cooperation through product development[32]. - The company has increased its prepayments by 39.89% due to tightening raw material supplies, impacting its operational costs[29]. - The company has a total of 3,000 million yuan in various bank financial products with annualized returns ranging from 2.22% to 3.91%[61]. - The company has maintained a diversified investment strategy across different banks[62]. - The company continues to focus on financial product investments as a key strategy[62]. Risks and Challenges - The company faces risks including raw material supply and price fluctuations, exchange rate risks, and environmental protection risks[4]. - The company plans to enhance procurement management to mitigate the impact of raw material price fluctuations, which significantly affect operating costs and gross margins[70]. - The company is facing risks related to environmental protection and safety production, as the pesticide industry generates waste and involves hazardous materials[70]. - Future capital expenditures for new project construction are expected to be substantial, potentially leading to increased depreciation and operational costs, which may adversely affect performance in the short term[71]. Environmental Management - The company has established a comprehensive environmental management system, including regulations for wastewater discharge and solid waste management[98]. - Jiangsu Zhongqi has implemented advanced wastewater treatment technologies, including a high-efficiency catalytic oxidation process and a combination of hydrolysis-acidification, anoxic, and aerobic processes[100]. - The company collaborates with leading research institutions to enhance its environmental protection technologies[99]. - The company has a dedicated environmental management organization to oversee compliance with pollution control regulations[98]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 10,561[118]. - Major shareholder Wu Yaojun holds 30.10% of shares, totaling 39,736,620 shares[118]. - Major shareholder Zhou Xuejin holds 15.66% of shares, totaling 20,675,920 shares[118]. - The total number of shares held by directors and senior management at the end of the period was 23,416,988 shares, with a decrease of 2,820,080 shares during the period[127]. Compliance and Governance - The company’s financial statements comply with the requirements of the enterprise accounting standards, reflecting a true and complete financial status[179]. - The company has not reported any significant litigation or arbitration matters during the reporting period[78]. - The company has not faced any production restrictions or significant adverse impacts from past administrative penalties, ensuring normal operations[105].

江苏中旗科技股份有限公司 2019 年第一季度报告全文 江苏中旗科技股份有限公司 2019 年第一季度报告 2019 年 04 月 1 江苏中旗科技股份有限公司 2019 年第一季度报告全文 第一节 重要提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真 实、准确、完整，不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和 连带的法律责任。 所有董事均已出席了审议本次季报的董事会会议。 公司负责人吴耀军、主管会计工作负责人顾游及会计机构负责人(会计主管 人员)刘红妮声明：保证季度报告中财务报表的真实、准确、完整。 2 江苏中旗科技股份有限公司 2019 年第一季度报告全文 第二节 公司基本情况 一、主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 □ 是 √ 否 | | 本报告期 | 上年同期 | 本报告期比上年同期增减 | | | --- | --- | --- | --- | --- | | 营业总收入（元） | 549,947,693.26 | 415,131,216.93 | | 32.48% | | 归属于上市公司股东的净利润（元） | 74,820,744.06 ...

Financial Performance - The company's operating revenue for 2018 was ¥1,649,849,487.54, representing a 27.40% increase compared to ¥1,295,059,730.70 in 2017[15] - The net profit attributable to shareholders for 2018 was ¥209,158,538.75, an increase of 78.27% from ¥117,325,262.97 in 2017[15] - The net profit after deducting non-recurring gains and losses was ¥205,400,733.13, up 86.17% from ¥110,332,289.28 in 2017[15] - The net cash flow from operating activities was ¥280,165,159.26, a 74.71% increase from ¥160,360,358.88 in 2017[15] - The basic earnings per share for 2018 was ¥2.850, reflecting a growth of 78.13% compared to ¥1.600 in 2017[15] - The total assets at the end of 2018 amounted to ¥2,238,334,869.43, a 30.04% increase from ¥1,721,254,589.49 at the end of 2017[15] - The net assets attributable to shareholders increased by 18.75% to ¥1,197,173,444.48 from ¥1,008,147,701.78 in 2017[15] - The weighted average return on equity for 2018 was 19.04%, up from 12.28% in 2017[15] Dividend Policy - The company plans to distribute a cash dividend of ¥8.00 per 10 shares, based on a total of 73,350,000 shares[4] - The total distributable profit for the year was RMB 570.50 million, with cash dividends accounting for 100% of the profit distribution[103] - The company achieved a net profit attributable to shareholders of RMB 209.16 million for the year 2018, resulting in a cash dividend payout ratio of 28.06%[106] - The company has a cash dividend policy that mandates at least 20% of the distributable profit to be distributed in cash annually, or 60% over three years[97] Market Position and Competition - The company maintained a leading position in the market for products such as chlorfluoropyrrolidine and thiamethoxam, recognized as one of the top 500 chemical companies in China[29] - The pesticide industry accounted for ¥1,642,792,308.67, representing 99.57% of total revenue, with a year-on-year growth of 28.22%[44] - The company’s main business revenue is driven by its pesticide business, which provides a stable profit source despite increasing market competition[28] - The pesticide industry is characterized by high entry barriers and consolidation, with major global players completing large-scale mergers, impacting domestic competition[88] Research and Development - The company has invested 46.92 million yuan in the R&D center project, which is now operational[39] - The number of R&D personnel increased to 150, representing 11.27% of the workforce[56] - Research and development expenses totaled ¥54,144,928.39, accounting for 3.28% of total revenue, slightly down from 3.30% in 2017[57] - The company holds 38 patents, including 17 invention patents and 21 utility model patents, with additional applications pending[41] Risks and Challenges - The company faced risks related to raw material supply and price fluctuations, exchange rate risks, and environmental protection[4] - The company will manage exchange rate risks through export trade financing and foreign exchange derivatives, as half of its revenue comes from exports[92] - The company faces risks related to raw material supply and price fluctuations, which significantly impact operating costs and gross margins[91] Environmental and Social Responsibility - The company emphasizes corporate social responsibility, ensuring transparency and timely information disclosure to shareholders[163] - The company has established various environmental management systems, including wastewater discharge management regulations and emergency response plans for pollution incidents[167] - The company has constructed rotary kilns and liquid incineration facilities for hazardous waste disposal, which are currently in normal operation[169] - The company has developed an emergency response plan for environmental incidents and conducted drills to evaluate the effectiveness of these plans[170] Investment and Capital Management - The total investment amount for the reporting period was 487.90 million yuan, representing a year-on-year increase of 107.99%[69] - The company reported a financial derivative loss of RMB 4,205,291 in the current period, with total financial derivatives amounting to RMB 101,566,000[74] - The company has a remaining balance of RMB 28,407,000 in the special account for raised funds as of December 31, 2018[78] - The company will optimize investment management for new projects to mitigate risks associated with large capital expenditures and ensure timely project completion[91] Shareholder Structure and Governance - The total number of shares is 73,350,000, with 53.11% being restricted shares and 46.89% being unrestricted shares[176] - Major shareholders include Wu Yaojun with 30.10% and Zhou Xuejin with 17.17% of the shares[181] - The company has established a complete decision-making process for profit distribution, with independent directors fulfilling their responsibilities[101] - The company’s board includes experienced professionals with backgrounds in various industries, enhancing its governance structure[192]

Financial Performance - Net profit attributable to shareholders rose by 231.18% to CNY 52,013,231.71 for the current period[7]. - Operating revenue for the current period reached CNY 382,986,909.52, reflecting a growth of 48.02% year-on-year[7]. - Basic earnings per share increased by 238.10% to CNY 0.71[7]. - The weighted average return on net assets improved by 208.59% to 5.03%[7]. - The net profit after deducting non-recurring gains and losses surged by 264.92% to CNY 54,006,176.53 for the current period[7]. - The total comprehensive income for the current period was ¥52,013,231.71, compared to ¥15,705,493.45 in the previous period, reflecting a growth of 231.73%[40]. - The total profit for the current period was ¥46,804,826.82, up from ¥29,514,709.29, showing a growth of 58.61%[40]. - Net profit for the current period was ¥132,898,580.64, up 40% from ¥94,960,725.55 in the previous period[48]. - Total profit for the current period was ¥155,791,889.63, a 38.2% increase from ¥112,683,321.08 in the previous period[48]. Assets and Liabilities - Total assets increased by 20.32% to CNY 2,070,966,238.67 compared to the end of the previous year[7]. - The company's total assets increased to ¥1,817,413,373.41, up from ¥1,534,076,159.49 at the beginning of the year, reflecting a growth of 18.5%[32]. - Current liabilities rose to ¥456,496,050.11, compared to ¥410,418,687.83 at the start of the period, indicating a 11.2% increase[32]. - Long-term borrowings increased to ¥209,200,222.70, up from ¥84,865,899.16, marking a growth of 146.5%[32]. - Cash and cash equivalents decreased to ¥359,812,726.44 from ¥458,829,130.56, a decline of 21.6%[30]. - Cash and cash equivalents at the end of the period totaled ¥290,494,861.57, down from ¥428,453,031.94 at the beginning of the period[55]. Cash Flow - Cash flow from operating activities for the year-to-date period was CNY 90,244,400.83, up 149.16%[7]. - Cash flow from operating activities improved by 149.16%, totaling CNY 90,244,400.83, driven by faster collection of receivables[16]. - Cash inflow from financing activities totaled ¥303,194,322.01, compared to ¥82,842,042.65 in the previous period, indicating a significant increase[55]. - Net cash flow from financing activities was ¥146,437,725.71, a turnaround from a negative cash flow of ¥12,030,051.35 in the previous period[55]. - The net cash flow from investing activities decreased by 308.87%, totaling CNY -375,507,835.14, reflecting ongoing investments in new projects[16]. Shareholder Information - The total number of shareholders at the end of the reporting period was 8,874[11]. - The largest shareholder, Wu Yaojun, holds 30.10% of the shares, with 22,075,900 shares pledged[11]. Operational Highlights - The company's operating revenue reached CNY 1,179,320,849.71, representing a 30.00% increase compared to the previous period[15]. - Operating costs for the same period were ¥318,565,895.44, up 33.2% from ¥239,131,743.34 year-over-year[35]. - The company reported a significant increase in research and development expenses, totaling ¥5,534,955.62, compared to ¥9,170,038.42 in the previous year[35]. - The company's investment income for the current period was ¥660,667.28, compared to a loss of ¥37,446.25 in the previous period[39]. - The company plans to continue expanding its market presence and investing in new technologies to drive future growth[39]. Regulatory and Compliance - The company faced an administrative penalty of CNY 150,000 due to environmental regulation violations, but it did not significantly impact operations[17]. - The company reported no significant non-recurring gains or losses that were reclassified as regular income[9].